3071 – 3080 of 3089
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Cystatins - Extra- and Intracellular Cysteine Protease Inhibitors: High-level Secretion and Uptake of Cystatin C in Human Neuroblastoma Cells.
(
- Contribution to journal › Article
-
Mark
Population-Based Study of the Risk of Second Primary Contralateral Breast Cancer Associated With Carrying a Mutation in BRCA1 or BRCA2.
(
- Contribution to journal › Article
-
Mark
Relapsed childhood high hyperdiploid acute lymphoblastic leukemia: presence of preleukemic ancestral clones and the secondary nature of microdeletions and RTK-RAS mutations.
(
- Contribution to journal › Article
-
Mark
Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patients.
(
- Contribution to journal › Article
-
Mark
Genome-wide transcription factor binding site/promoter databases for the analysis of gene sets and co-occurrence of transcription factor binding motifs.
(
- Contribution to journal › Article
-
Mark
Changing clinical presentation of angiosarcomas after breast cancer: from late tumors in edematous arms to earlier tumors on the thoracic wall.
(
- Contribution to journal › Article
-
Mark
The interface of population-based cancer registries and biobanks in etiological and clinical research - current and future perspectives.
(
- Contribution to journal › Article
-
Mark
Genetic profiles distinguish different types of hereditary ovarian cancer.
(
- Contribution to journal › Article
-
Mark
Swedish CDKN2A mutation carriers do not present the atypical mole syndrome phenotype.
(
- Contribution to journal › Article
-
Mark
Young age at diagnosis is a risk factor for negative late socio-economic effects after acute lymphoblastic leukemia in childhood.
(
- Contribution to journal › Article